XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
25.10
-1.50 (-5.64%)
May 21, 2025, 3:39 PM - Market open
XOMA Royalty Market Cap
XOMA Royalty has a market cap or net worth of $300.37 million as of May 21, 2025. Its market cap has increased by 4.26% in one year.
Market Cap
300.37M
Enterprise Value
322.17M
1-Year Change
4.26%
Ranking
Category
Stock Price
$25.10
Market Cap Chart
Since December 1, 1998, XOMA Royalty's market cap has increased from $151.40M to $300.37M, an increase of 98.39%. That is a compound annual growth rate of 2.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 20, 2025 | 318.30M | 2.81% |
Dec 31, 2024 | 309.60M | 45.69% |
Dec 29, 2023 | 212.50M | 0.85% |
Dec 30, 2022 | 210.70M | -10.64% |
Dec 31, 2021 | 235.80M | -51.52% |
Dec 31, 2020 | 486.40M | 103.60% |
Dec 31, 2019 | 238.90M | 125.16% |
Dec 31, 2018 | 106.10M | -63.40% |
Dec 29, 2017 | 289.90M | 1,036.86% |
Dec 30, 2016 | 25.50M | -83.86% |
Dec 31, 2015 | 158.00M | -59.01% |
Dec 31, 2014 | 385.50M | -38.46% |
Dec 31, 2013 | 626.40M | 220.08% |
Dec 31, 2012 | 195.70M | 396.70% |
Dec 30, 2011 | 39.40M | -64.76% |
Dec 31, 2010 | 111.80M | -19.57% |
Dec 31, 2009 | 139.00M | 69.31% |
Dec 31, 2008 | 82.10M | -81.63% |
Dec 31, 2007 | 447.00M | 100.18% |
Dec 29, 2006 | 223.30M | 61.69% |
Dec 30, 2005 | 138.10M | -37.68% |
Dec 31, 2004 | 221.60M | -59.61% |
Dec 31, 2003 | 548.60M | 84.40% |
Dec 31, 2002 | 297.50M | -56.92% |
Dec 31, 2001 | 690.50M | 7.32% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.89B |
Johnson & Johnson | 366.90B |
AbbVie | 328.04B |
Novo Nordisk | 293.82B |
UnitedHealth Group | 286.56B |
Abbott Laboratories | 235.83B |
Novartis AG | 215.48B |
AstraZeneca | 214.95B |